Moderna seeks full rego for Spikevax

Moderna COVID-19 vaccine. Source: Flickr/Governor Tom Wolf under Creative Commons licence.
Moderna’s Spikevax is set to be the first of Australia’s provisionally approved COVID-19 vaccines to undergo an evaluation to transition to full registration.  The Therapeutic Goods Administration (TGA) revealed Moderna Australia has lodged an application for the vaccine to be granted full market authorisation for the immunisation of individuals aged six years and older, and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 2000 jobs under threat; supermarkets shock
Next Stop pretending full scope ‘isn’t going to cost’